Related Experiment Video
Updated: Jul 2, 2026

08:20
Superior Auto-Identification of Trypanosome Parasites by Using a Hybrid Deep-Learning Model
Published on: October 27, 2023
Two-step deep-learning candidemia prediction model using two large time-sequence electronic health datasets
Hisato Yoshida1,2, Max W Adelman1,3,4,5, Laila Rasmy6
1Center for Infectious Diseases, Houston Methodist Research Institute, Houston, Texas, USA.
Medrxiv : the Preprint Server for Health Sciences
|March 23, 2026
Summary
A novel deep learning model effectively predicts candidemia risk, improving early detection of this bloodstream infection. This approach aids in timely antifungal therapy for high-risk patients.
Area of Science:
- Medical Informatics
- Computational Biology
- Infectious Diseases
Background:
- Candidemia is a life-threatening bloodstream infection with poor predictive accuracy using current methods.
- Delayed empiric antifungal therapy is common, even in high-risk individuals.
Purpose of the Study:
- To develop and validate a deep learning model for predicting 7-day candidemia risk.
- To implement a two-step framework integrating candidemia and mortality risk to guide antifungal therapy decisions.
Main Methods:
- A deep learning model (PyTorch_EHR) was developed using electronic health record data from two large cohorts (HMHS and MIMIC-IV).
- Model performance was compared against logistic regression, LightGBM, and existing candidemia scores.
- A two-step prediction framework combined candidemia and 30-day mortality risk models.
Main Results:
- The deep learning model outperformed other methods in predicting candidemia across both cohorts.
- The two-step framework identified additional candidemia cases, improving coverage for high-risk patients.
- A significant proportion of identified high-risk patients with high mortality did not receive empiric antifungal therapy.
Conclusions:
- A two-step deep learning framework can enhance early identification of patients at high risk for candidemia.
- This approach may facilitate more timely initiation of empiric antifungal therapy.
- Further prospective studies are needed to validate these findings.